Plasma Total Homocysteine Levels in Stroke Patients Screened for the Vitamin Intervention for Stroke Prevention Clinical Trial in the Era of Folate Fortification

Publisher： Karger

E-ISSN： 1423-0208|26|1|45-51

ISSN： 0251-5350

Source： Neuroepidemiology, Vol.26, Iss.1, 2005-12, pp. : 45-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vitamin Intervention for Stroke Prevention (VISP) Trial: Rationale and Design

By  

Neuroepidemiology, Vol. 20, Iss. 1, 2001-02 ,pp. : 16-25

Karger

Access to resources Recommend Favorite

The Changing Risk Factor Profile of Participants Enrolled in a Secondary Stroke Prevention Trial: Vitamin Intervention for Stroke Prevention

By  

Neuroepidemiology, Vol. 27, Iss. 4, 2006-12 ,pp. : 222-229

Karger

Access to resources Recommend Favorite

Cognitive Performance and Plasma Levels of Homocysteine, Vitamin B12, Folate and Lipids in Patients with Alzheimer Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 26, Iss. 4, 2008-10 ,pp. : 384-390

Karger

Access to resources Recommend Favorite

Can High-Sensitivity C-Reactive Protein and Plasma Homocysteine Levels Independently Predict the Prognosis of Patients with Functional Disability after First-Ever Ischemic Stroke?

By  

European Neurology, Vol. 64, Iss. 5, 2010-11 ,pp. : 304-310

Karger

Access to resources Recommend Favorite

An Analysis of Transcobalamin II Gene Polymorphisms and Serum Levels of Homocysteine, Folate and Vitamin B12 in Chinese Patients with Crohn's Disease

By  

Digestive Diseases, Vol. 35, Iss. 5, 2017-05 ,pp. : 463-471

Karger

Access to resources Recommend Favorite